ARID1A and ovarian clear cell cancer: Approximately 33% of ovarian clear cell carcinoma cases exhibit co-mutations of ARID1A and PIK3CA, which activate pro-inflammatory cytokine genes via the NF-kB pathway, thereby promoting tumor growth.